These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4149736)

  • 1. Pipradrol in mild depression: a controlled study.
    Rickels K; Schneider B; Pereira-Ogan JA; Perloff MM; Segal A; Vandervort W
    J Clin Pharmacol; 1974; 14(2):127-33. PubMed ID: 4149736
    [No Abstract]   [Full Text] [Related]  

  • 2. The re-evaluation of a central nervous system stimulant: pipradrol hydrochloride.
    Brauzer B; Goldstein BJ; Jacobson A; Steinbook R
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):780-4. PubMed ID: 4404873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Zung's test for the quantitative assessment of depression and its confirmation through the testing of a new anti-migraine drug Sandomigran].
    Klapetek J
    Cesk Neurol Neurochir; 1973 Oct; 36(5):298-303. PubMed ID: 4588664
    [No Abstract]   [Full Text] [Related]  

  • 4. WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients.
    Kaumeier S; Dohren J; Flach D
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):108-13. PubMed ID: 401705
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychopharmacologic investigations in healthy elderly volunteers: effects of pipradrol-vitamin (Alertonic) elixir and placebo in relation to research design.
    Shader RI; Harmatz JS; Kochansky GE; Cole JO
    J Am Geriatr Soc; 1975 Jun; 23(6):277-9. PubMed ID: 236337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM; Mielke DH; Spirtes MA; Swanson WC; Bost R
    Am J Psychiatry; 1974 Jun; 131(6):699-702. PubMed ID: 4597305
    [No Abstract]   [Full Text] [Related]  

  • 7. Penfluridol (R 16341) as a maintenance therapy in chronic psychotic patients: a double-blind clinical evaluation.
    Roelofs GA
    Acta Psychiatr Scand; 1974; 50(2):219-24. PubMed ID: 4604881
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of nortriptyline in the treatment of endogenous depression.
    Kragh-Sorensen P; Hansen CE; Asberg M
    Acta Psychiatr Scand; 1973; 49(4):444-56. PubMed ID: 4583402
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 10. Pimozide in chronic schizophrenic patients.
    Huber W; Serafetinides EA; Colmore JP; Clark M
    J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748
    [No Abstract]   [Full Text] [Related]  

  • 11. Amitriptyline in anxious-depressed outpatients: a controlled study.
    Rickels K; Csanalosi I; Chung HR; Case WG; Pereira-Ogan A; Downing RW
    Am J Psychiatry; 1974 Jan; 131(1):25-30. PubMed ID: 4585770
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dibenzepin in depression. A controlled clinical trial].
    Vinar O; Taussigová D
    Act Nerv Super (Praha); 1967 Nov; 9(4):359-61. PubMed ID: 4889063
    [No Abstract]   [Full Text] [Related]  

  • 14. Baclofen treatment in chronic schizophrenia: a clinical trial.
    Bigelow LB; Nasrallah H; Carman J; Gillin JC; Wyatt RJ
    Am J Psychiatry; 1977 Mar; 134(3):318-20. PubMed ID: 320885
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
    Ota KY; Kurland AA; Slotnick VB
    J Clin Pharmacol; 1974 Apr; 14(4):202-9. PubMed ID: 4595986
    [No Abstract]   [Full Text] [Related]  

  • 16. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
    Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D
    Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069
    [No Abstract]   [Full Text] [Related]  

  • 17. L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders.
    Prange AJ; Wilson IC; Lynn CW; Alltop LB; Stikeleather RA
    Arch Gen Psychiatry; 1974 Jan; 30(1):56-62. PubMed ID: 4587067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hyperlipidemia with a new drug, tibric acid].
    Carmena R; González R Florez J; Sanchis J
    Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065
    [No Abstract]   [Full Text] [Related]  

  • 19. Lithium prophylaxis in recurrent affective illness.
    Prien RF; Klett CJ; Caffey EM
    Am J Psychiatry; 1974 Feb; 131(2):198-203. PubMed ID: 4587809
    [No Abstract]   [Full Text] [Related]  

  • 20. [Zung's test for the quantitative assessment of depression and its confirmation during the testing of a new anti-migraine agent Sandomigran].
    Klapetek J
    Cesk Neurol; 1973 Sep; 36(5):298-303. PubMed ID: 4581588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.